Legend Biotech Corp - Ordinary Shares (LEGN) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2020 to Q4 2025

Type / Class
Equity / Ordinary Shares
Symbol
LEGN on Nasdaq
Shares outstanding
368,659,889
Price per share
$19.34
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
87,273,097
Total reported value
$1,896,912,715
% of total 13F portfolios
0%
Share change
+3,007,573
Value change
+$20,491,221
Number of holders
191
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Legend Biotech Corp - Ordinary Shares (LEGN) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FMR LLC 13% -13% $1,049,921,245 -$147,815,434 48,294,445 -12% FMR LLC 31 Dec 2025
PRICE T ROWE ASSOCIATES INC /MD/ 3.7% $233,379,028 6,808,023 T. Rowe Price Associates, Inc. 31 Dec 2024

As of 31 Dec 2025, 191 institutional investors reported holding 87,273,097 shares of Legend Biotech Corp - Ordinary Shares (LEGN). This represents 24% of the company’s total 368,659,889 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Legend Biotech Corp - Ordinary Shares (LEGN) together control 20% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FMR LLC 6.6% 24,268,223 -12% 0.03% $527,591,163
SUVRETTA CAPITAL MANAGEMENT, LLC 1.8% 6,608,629 +73% 3.6% $143,671,594
WESTFIELD CAPITAL MANAGEMENT CO LP 1.7% 6,164,677 +1.2% 0.56% $134,020,083
HHLR ADVISORS, LTD. 1.6% 5,984,550 0% 4.2% $130,104,117
DEERFIELD MANAGEMENT COMPANY, L.P. 1.6% 5,932,000 +100% 1.7% $128,961,680
BlackRock, Inc. 1.2% 4,276,913 -4.8% 0% $92,980,090
Point72 Asset Management, L.P. 0.76% 2,784,806 0.09% $60,541,682
Artisan Partners Limited Partnership 0.64% 2,341,074 -8.1% 0.08% $50,894,949
GOLDMAN SACHS GROUP INC 0.59% 2,174,535 +106% 0.01% $47,274,391
ALLIANCEBERNSTEIN L.P. 0.41% 1,517,067 -7.1% 0.01% $32,981,037
STATE STREET CORP 0.41% 1,516,368 +31% 0% $32,965,840
BRAIDWELL LP 0.35% 1,298,142 -29% 0.9% $28,221,607
Davern Capital Partners, LP 0.29% 1,056,668 0% 7.4% $22,971,962
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 0.26% 956,824 -7% 6.3% $20,801,354
JPMORGAN CHASE & CO 0.26% 945,694 +205% 0% $20,559,386
Capital International Investors 0.26% 941,600 0% 0% $20,470,384
JOHNSON & JOHNSON 0.22% 814,586 0% 3.2% $17,709,100
IvyRock Asset Management (HK) Ltd 0.22% 804,000 -6.2% 9.2% $17,478,960
MARSHALL WACE, LLP 0.21% 755,953 +4130% 0.02% $16,434,418
ArrowMark Colorado Holdings LLC 0.2% 721,790 -23% 0.35% $15,691,715
TWO SIGMA ADVISERS, LP 0.19% 689,600 -4.7% 0.03% $14,991,904
ACADIAN ASSET MANAGEMENT LLC 0.16% 582,154 0.02% $12,647,000
Hudson Bay Capital Management LP 0.16% 575,000 +161% 0.07% $12,500,500
GEODE CAPITAL MANAGEMENT, LLC 0.15% 555,436 +2.9% 0% $11,980,293
TWO SIGMA INVESTMENTS, LP 0.14% 526,070 +46% 0.02% $11,436,762

Institutional Holders of Legend Biotech Corp - Ordinary Shares (LEGN) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 87,273,097 $1,896,912,715 +$20,491,221 $21.74 191
2025 Q3 83,685,243 $2,727,887,108 -$49,026,070 $32.61 198
2025 Q2 84,637,633 $3,002,800,929 -$25,701,898 $35.49 209
2025 Q1 85,585,612 $2,906,390,112 -$451,293,431 $33.93 205
2024 Q4 99,259,008 $3,230,144,565 +$188,311,867 $32.54 205
2024 Q3 91,083,902 $4,438,353,408 +$43,810,918 $48.73 204
2024 Q2 91,534,759 $4,053,943,715 +$152,693,975 $44.29 173
2024 Q1 86,480,093 $4,850,469,897 +$24,114,634 $56.09 187
2023 Q4 85,815,138 $5,163,245,741 -$85,151,940 $60.17 204
2023 Q3 85,989,090 $5,775,420,098 +$112,052,258 $67.17 198
2023 Q2 84,064,242 $5,802,906,378 +$1,140,343,215 $69.03 191
2023 Q1 68,026,089 $3,279,762,243 +$214,876,512 $48.22 158
2022 Q4 63,494,614 $3,169,508,515 -$28,958,118 $49.92 167
2022 Q3 63,810,382 $2,603,349,501 +$399,712,134 $40.80 154
2022 Q2 52,707,652 $2,898,825,468 +$118,361,366 $55.00 147
2022 Q1 51,010,221 $1,853,796,102 +$18,669,383 $36.34 137
2021 Q4 50,201,932 $2,340,358,513 +$500,109,001 $46.61 137
2021 Q3 39,005,848 $1,971,657,000 +$572,564,727 $50.56 87
2021 Q2 28,328,593 $1,162,838,000 +$121,639,656 $41.05 84
2021 Q1 26,391,052 $765,864,420 +$30,109,528 $29.02 69
2020 Q4 25,444,505 $716,732,000 +$16,894,703 $28.16 60
2020 Q3 24,479,702 $752,680,000 -$30,044,903 $30.87 50
2020 Q2 24,613,241 $1,036,097,000 +$1,036,097,000 $42.56 76